Effects of switching from olanzapine to aripiprazole on the metabolic profiles of patients with schizophrenia and metabolic syndrome: a double-blind, randomized, open-label study

BACKGROUND: Patients with schizophrenia suffer high rates of metabolic derangements on some antipsychotic medications that predispose them to cardiovascular diseases. Keeping this fact in mind, we planned this open-label study to see the effect on various metabolic parameters after switching stable...

Descripción completa

Detalles Bibliográficos
Autores principales: Wani, Rayees Ahmad, Dar, Mansoor Ahmad, Chandel, Rajesh Kumar, Rather, Yasir Hassan, Haq, Inaamul, Hussain, Arshad, Malla, Altaf Ahmad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4364593/
https://www.ncbi.nlm.nih.gov/pubmed/25792838
http://dx.doi.org/10.2147/NDT.S80925

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4364593/
https://www.ncbi.nlm.nih.gov/pubmed/25792838
http://dx.doi.org/10.2147/NDT.S80925

Ejemplares similares